1. Home
  2. CCLD vs VRCA Comparison

CCLD vs VRCA Comparison

Compare CCLD & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareCloud Inc.

CCLD

CareCloud Inc.

N/A

Current Price

$1.99

Market Cap

98.6M

Sector

Technology

ML Signal

N/A

Logo Verrica Pharmaceuticals Inc.

VRCA

Verrica Pharmaceuticals Inc.

N/A

Current Price

$4.15

Market Cap

88.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CCLD
VRCA
Founded
1999
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
98.6M
88.0M
IPO Year
2013
2018

Fundamental Metrics

Financial Performance
Metric
CCLD
VRCA
Price
$1.99
$4.15
Analyst Decision
Buy
Strong Buy
Analyst Count
2
7
Target Price
$7.33
★ $13.83
AVG Volume (30 Days)
★ 205.3K
40.9K
Earning Date
11-05-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 135.71
N/A
EPS
★ N/A
N/A
Revenue
★ $120,499,000.00
$35,577,000.00
Revenue This Year
$8.14
N/A
Revenue Next Year
$9.63
$58.01
P/E Ratio
★ N/A
N/A
Revenue Growth
8.72
★ 370.22
52 Week Low
$1.93
$3.28
52 Week High
$3.81
$9.82

Technical Indicators

Market Signals
Indicator
CCLD
VRCA
Relative Strength Index (RSI) 40.85 41.90
Support Level N/A $4.25
Resistance Level $2.42 $4.97
Average True Range (ATR) 0.07 0.31
MACD 0.00 -0.01
Stochastic Oscillator 33.96 25.25

Price Performance

Historical Comparison
CCLD
VRCA

About CCLD CareCloud Inc.

CareCloud Inc delivers flexible, tech-enabled solutions for healthcare providers of all sizes and multi-specialties across the U.S. It is a healthcare technology company offering cloud-based solutions that simplify clinical, administrative, and financial workflows for medical practices of all sizes. Its comprehensive suite includes Electronic Health Records (EHRs), Practice Management, Revenue Cycle Management (RCM), Medical Billing, Telehealth, and Patient Experience solutions. The group helps practices increase efficiency, improve patient care, and drive sustainable growth-all while ensuring HIPAA compliance and seamless integration. The operating segments of the group are Healthcare IT, which is the key revenue-generating segment, and Medical Practice Management.

About VRCA Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Its commercial product and portfolio of product candidates are clinician administered therapies in areas of high unmet need. This product portfolio consists of one product with an approved indication for molluscum contagiosum, or molluscum, with the potential for several follow-on indications, as well as additional pipeline product candidates. Its commercial product, YCANTH (VP-102), for the treatment of molluscum in adult and pediatric patients two years of age and older. YCANTH (VP-102) is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin.

Share on Social Networks: